Novel Technique Versus Conventional Subepithelial Connective Tissue Graft in Treatment of Ridge Contour Defects
Launched by MISR INTERNATIONAL UNIVERSITY · May 26, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods to improve the soft tissues around the gums for patients with a specific type of ridge defect in the mouth. One method is the traditional subepithelial connective tissue graft, while the other is a new technique called the denuded interpositional pedicled rolled flap (DIPRF). Both techniques aim to prepare the area for future dental work, like implants or fixed restorations, which help replace missing teeth.
To participate in this study, you need to be an adult between the ages of 18 and 50, and have certain conditions in your mouth that make you a good candidate for these treatments. You should have healthy gums and good oral hygiene, and you will need to agree to provide informed consent to take part in the trial. If you join, you can expect to receive one of the two treatments and to have regular check-ups to monitor your progress. The trial is currently looking for participants, and it's important to note that pregnant women and smokers who smoke more than ten cigarettes a day are not eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adults above the age of 18 to 50 years.
- • 2. Males and females as confirmed by asking the female patients about whether they are pregnant or not
- • 3. Patient's with Seibert classification class I requiring future rehabilitation of one or more premolar region and sound adjacent teeth.
- • 4. Soft tissue thickness on the palatal tissues more than 6mm at the site of harvesting the graft.
- • 5. Presence of Mandibular posterior teeth opposing the tooth to be replaced for occlusion.
- • 6. Clinically healthy soft tissues with no signs of clinical pathology of the soft tissue.
- • 7. Good oral hygiene.
- • 8. Patient accepts to sign an informed consent.
- • 9. ASA I or ASA II Patient.
- Exclusion Criteria:
- • 1. Patients with ridge defects due to bone defect
- • 2. Smoker patients who smoke more than 10 cigarettes per day
- • 3. Pregnant females
Trial Officials
Hebattallah A Mattar
Principal Investigator
Misr International University
About Misr International University
MISR International University is a distinguished educational institution dedicated to advancing health sciences and clinical research. As a clinical trial sponsor, the university emphasizes innovative methodologies and rigorous scientific standards to enhance the quality of healthcare solutions. Committed to fostering collaboration between academia and industry, MISR International University actively engages in clinical trials that aim to address pressing medical challenges while ensuring ethical practices and patient safety. Through its comprehensive approach, the university seeks to contribute significantly to the body of clinical knowledge and improve health outcomes in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0